Back to results
US 12,760,059 B2Granted
Glucocorticoid receptor modulators
AssigneeTrustees of Dartmouth College
InventorGlenn C. Micalizio
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to polycyclic (e.g., tetracyclic) glucocorticoid receptor (GR) modulators, synthetic methods for preparing such GR modulators, and methods of using such GR modulators to treat a glucocorticoid-dependent condition, such as cancer or hypercortisolism. Exemplary compounds have quaternary centers at C9 and C13 in which the quaternary center at C9 projects a substituent on the opposite face of the tetracycle as the substituent at C13.
Claims13
A compound or pharmaceutically acceptable salt thereof, wherein the compound has a structure corresponding to Formula (IV-A1):
- wherein Cy is an optionally substituted mono- or poly-cyclic moiety selected from the group consisting of C6-15-aryl, 5-to 15-membered heteroaryl, C3-15-cycloalkyl, C3-15-cycloalkenyl, 3-to 15-membered heterocycloalkyl, and 3- to 15-membered heterocycloalkenyl;
- X is absent or selected from the group consisting of —NRZ—, —C(RZ)2—, —O—, —C(O)—, and —S(O)y—, wherein each RZ is independently hydrogen, C1-6-alkyl, C1-6-haloalkyl, C2-6-alkenyl, C2-6-haloalkenyl, C2-6-alkynyl, C2-6-haloalkynyl, or C3-8-cycloalkyl, and y is 0, 1, or 2;
- R9 is C1-10-alkyl or C1-10-haloalkyl, each of which is optionally interrupted by one or more of —O—, —NRZ—, —C(O)—, —C(O)O—, —OC(O)—, —C(O)NRZ—, and —NRZC(O)—;
- or
- R9 is
- wherein Q is absent or selected from the group consisting of C1-C10-alkylene, C1-C10-haloalkylene, C2-C10-alkenylene, C2-C10-haloalkenylene, C2-C10-alkynylene, C2-C10-haloalkynylene, each of which is optionally interrupted by one or more of —O—, —NRZ—, —C(O)—, —C(O)O—, —OC(O)—, —C(O)NRZ—, —NRZC(O)—, —S(O)y—, —S(O)yNRZ—, —NRZS(O)y—, —C(S)NRZ—, —NRZC(S)—;
- and
- E is selected from the group consisting of C6-10-aryl, 5- to 10-membered heteroaryl, C3-8-cycloalkyl, or 3- to 8-heterocycloalkyl;
- R13 is selected from the group consisting of C1-10-alkyl, C1-10-haloalkyl, C2-10-alkenyl, C2-10-haloalkenyl, C2-10-alkynyl, C2-10-haloalkynyl, each of which is optionally interrupted by one or more of —O—, —NRZ—, —C(O)—, —C(O)O—, —OC(O)—, —C(O)NRZ—, —NRZC(O)—, —S(O)y—, —S(O)yNRZ—, —NRZS(O)y, —C(S)NRZ—, and —NRZC(S)—;
- RD is selected from the group consisting of hydrogen C1-10-alkyl, C1-10-haloalkyl, C2-10-alkenyl, C2-10-haloalkenyl, C2-10-alkynl, C2-10-haloalkynyl, —(CH2)m- C6-10-aryl, —(CH2)m-5- to 10-membered heteroaryl;
- m is an integer selected from the group consisting of 0, 1, 2, and 3;
- wherein any C6-10-aryl, 5- to 10-membered heteroaryl, C3-8-cycloalkyl, or 3- to 8-heterocycloalkyl is optionally substituted with one or more halogen, hydroxy, C1-6-alkyl, C1-6-haloalkyl, or C1-6-alkoxy.
9 more elements
Dependencies are inferred from the claim text.